Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 22, 2011
Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2Isao Miyashiro, Hiroshi Furukawa, Mitsuru Sasako, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 20, 2002
Determining prognostic factors for gastric cancer using the regression tree methodYoshitaka Yamamura, Toshifusa Nakajima, Keiichiro Ohta, et al.
Clinical Journal of Gastroenterology|October 23, 2012
Natural history of gastric cancer-a case followed up for eight years: early to advanced gastric cancerJunko Fujisaki, Toshifusa Nakajima, Toshiaki Hirasawa, et al.
Journal of Cancer|August 19, 2017
Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United StatesMichitaka Honda, Sandra L Wong, Mark A Healy, et al.
Cancer Chemotherapy and Pharmacology|March 19, 2011
Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancerMitsugu Kochi, Wataru Ichikawa, Eiji Meguro, et al.
Cancer Science|January 12, 2011
Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patientsShogo Kikuchi, Yuki Obata, Kiyoko Yagyu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1Atsushi Nashimoto, Toshifusa Nakajima, Hiroshi Furukawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerMitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2013
FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II studyMitsugu Kochi, Yuji Akiyama, Tatsuya Aoki, et al.
Pageof 4